The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Neuroinflammatory processes in Parkinson's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“[4] Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E.”
BackgroundGreen, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,205
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., & Beckman, J. S. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90431-u · Cited by 1,495
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 2×
“[3] Hirsch EC, Graybiel AM, Agid Y.”
BackgroundApoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 3×
“Other anti-inflammatory drugs such as minocycline have also been shown to protect DA neurons against MPTP intoxication [69].”
BackgroundInfluentialγδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
Hayday, A. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.975 · Cited by 1,136
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 4×
“[39] Liberatore GT, JacksonLewis V, Vukosavic S, Mandir AS, Vila M,”
BackgroundResultInfluentialMechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
Dawson, V., Dawson, T., Bartley, D., Uhl, G., & Snyder, S. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02651.1993 · Cited by 1,014
Hartmann, A., Hunot, S., Michel, P. P., Muriel, M.-P., Vyas, S., Faucheux, B. A., Mouatt-Prigent, A., Turmel, H., Srinivasan, A., Ruberg, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556597 · Cited by 715
Self-citationMurine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE
Wang, S., Miura, M., Jung, Y.-K., Zhu, H., Li, E., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)80943-5 · Cited by 698
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M.-P., Ruberg, M., Faucheux, B. A., Agid, Y., & Hirsch, E. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7531 · Cited by 678
Self-citationImmunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed · Cited by 660
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Self-citationNonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Self-citationImmunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Self-citationProtein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
Failure of the ubiquitin-proteasome system in Parkinson’s disease
McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519
Changes in cytokines and neurotrophins in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6301-6_19 · Cited by 510
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Glutathione peroxidase, glial cells and Parkinson's disease
Damier, P., Hirsch, E. C., Zhang, P., Agid, Y., & Javoy-Agid, F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90175-f · Cited by 466
Self-citationHistochemical detection of apoptosis in Parkinson's disease
Mochizuki, H., Goto, K., Mori, H., & Mizuno, Y. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00336-z · Cited by 452
The Role of Glial Reaction and Inflammation in Parkinson's Disease
HIRSCH, E. C., BREIDERT, T., ROUSSELET, E., HUNOT, S., HARTMANN, A., & MICHEL, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449
Self-citationGlial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Brain microglia constitutively express β-2 integrins
Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426
Self-citationSchulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020936.x · Cited by 417
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
Self-citationCicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., & Kühn, L. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06038.x · Cited by 401
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Herrera, A. J., Castaño, A., Venero, J. L., Cano, J., & Machado, A. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0289 · Cited by 392
Dehmer, T., Heneka, M. T., Sastre, M., Dichgans, J., & Schulz, J. B. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382
Kurkowska-Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379
Breidert, T., Callebert, J., Heneka, M. T., Landreth, G., Launay, J. M., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 373
Self-citationSriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain Injury
Sullivan, P. G., Thompson, M. B., & Scheff, S. W. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7197 · Cited by 344
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
Höglinger, G. U., Féger, J., Prigent, A., Michel, P. P., Parain, K., Champy, P., Ruberg, M., Oertel, W. H., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01533.x · Cited by 331
Self-citationMirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309
Cytokines in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6284-2_12 · Cited by 308
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
Gao, H.-M., Liu, B., Zhang, W., & Hong, J.-S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0109fje · Cited by 306
Parain, K., Murer, M. G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00021 · Cited by 303
Self-citationMogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Hartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270
Self-citationPennathur, S., Jackson-Lewis, V., Przedborski, S., & Heinecke, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34621 · Cited by 265
Champy, P., Höglinger, G. U., Féger, J., Gleye, C., Hocquemiller, R., Laurens, A., Guérineau, V., Laprévote, O., Medja, F., Lombès, A., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02138.x · Cited by 254
Self-citationIravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247
Grünblatt, E., Mandel, S., Maor, G., & Youdim, M. B. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00397.x · Cited by 246
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 238
Depino, A. M., Earl, C., Kaczmarczyk, E., Ferrari, C., Besedovsky, H., Del Rey, A., Pitossi, F. J., & Oertel, W. H. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03014.x · Cited by 236
Pantopoulos, K., & Hentze, M. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1267 · Cited by 220
Blood vessels change in the mesencephalon of patients with Parkinson's disease
Faucheux, B. A., Agid, Y., Hirsch, E. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218
Self-citationFaucheux, B. A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J. J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 218
Farkas, E., De Jong, G. I., de Vos, R. A. I., Jansen Steur, E. N. H., & Luiten, P. G. M. (2000) · Acta Neuropathologica · doi:10.1007/s004010000195 · Cited by 217
Molecular diversity of astrocytes with implications for neurological disorders
Bachoo, R. M., Kim, R. S., Ligon, K. L., Maher, E. A., Brennan, C., Billings, N., Chan, S., Li, C., Rowitch, D. H., Wong, W. H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402140101 · Cited by 216
Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice
Aubin, N., Curet, O., Deffois, A., & Carter, C. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71041635.x · Cited by 214
Sphingomyelin breakdown and cell fate
TESTI, R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10056-6 · Cited by 208
Barcia, C., Bahillo, A. S., Fernández‐Villalba, E., Bautista, V., Poza Y Poza, M., Fernández‐Barreiro, A., Hirsch, E. C., & Herrero, M. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206
Self-citationRotenone induces non‐specific central nervous system and systemic toxicity
Lapointe, N., St‐Hilaire, M., Martinoli, M., Blanchet, J., Gould, P., Rouillard, C., & Cicchetti, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0677fje · Cited by 187
Liu, J., Zhao, M. L., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170
Microglial response to 6-hydroxydopamine-induced substantia nigra lesions
Akiyama, H., & McGeer, P. L. (1989) · Brain Research · doi:10.1016/0006-8993(89)90857-3 · Cited by 169
Sugama, S., Yang, L., Cho, B. P., DeGiorgio, L. A., Lorenzl, S., Albers, D. S., Beal, M. F., Volpe, B. T., & Joh, T. H. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04085-4 · Cited by 164
Carvey, P. M. (2003) · Frontiers in Bioscience · doi:10.2741/1158 · Cited by 161
Ijzermans, J. N. M., & Marquet, R. L. (1989) · Immunobiology · doi:10.1016/s0171-2985(89)80049-x · Cited by 153
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease
Hirsch, É. C., Hunot, S., Faucheux, B. A., Agid, Y., Mizuno, Y., Mochizuki, H., Tatton, W. G., Tatton, N. A., & Olanow, W. C. (1999) · Movement Disorders · Cited by 153
Self-citationInducible Nitric-oxide Synthase and Nitric Oxide Production in Human Fetal Astrocytes and Microglia
Ding, M., Pierre, B. A. S., Parkinson, J. F., Medberry, P. S., Wong, J. L., Rogers, N. E., Ignarro, L. J., & Merrill, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11327 · Cited by 153
Furuya, T., Hayakawa, H., YAMADA, M., Yoshimi, K., Hisahara, S., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3309-03.2004 · Cited by 152
Mayer, E. J., Fawcett, J. W., & Dunnett, S. B. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90340-l · Cited by 147
Peterson, P. K., Hu, S., Anderson, W. R., & Chao, C. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.457 · Cited by 143
Increased cerebrospinal fluid concentration of nitrite in Parkinsonʼs disease
Qureshi, G. A., Baig, S., Bednar, I., Södersten, P., Forsberg, G., & Sidén, Å. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00013 · Cited by 135
Increase in Peripheral CD4 Bright+ CD8 Dull+ T Cells in Parkinson Disease
Hisanaga, K., 浅黄美沙, Itoyama, Y., & Iwasaki, Y. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1580 · Cited by 131
Experimental Destruction of Substantia Nigra Initiated by Parkinson Disease Immunoglobulins
Chen, S., Le, W.-D., Xie, W., Alexianu, M. E., Engelhardt, J. I., Siklós, L., & Appel, S. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.8.1075 · Cited by 130
Rockwell, P., Yuan, H., Magnusson, R., & Figueiredo-Pereira, M. E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1646 · Cited by 130
Leveugle, B., Faucheux, B. A., Bouras, C., Nillesse, N., Spik, G., Hirsch, É. C., Agid, Y., & Hof, P. R. (1996) · Acta Neuropathologica · doi:10.1007/s004010050468 · Cited by 125
Iron metabolism and Parkinson's disease.
Hirsch, É. C., & Faucheux, B. A. (1998) · PubMed · Cited by 124
González, M. V., Jiménez, B., Berciano, M. T., González‐Sancho, J. M., Caelles, C., Lafarga, M., & Múñoz, A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1199 · Cited by 123
Fran�ois, C., Savy, C., Jan, C., Tandé, D., Hirsch, É. C., & Yelnik, J. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000911)425:1<121::aid-cne10>3.0.co;2-g · Cited by 122
Jan, C., François, C., Tandé, D., Yelnik, J., Tremblay, L., Agid, Y., & Hirsch, É. C. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01351.x · Cited by 119
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 119
Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118
Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease
Schulte, T., Schöls, L. J., Müller, T. H., Woitalla, D., Berger, K., & Krüger, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00301-4 · Cited by 117
Ling, Z. D., Chang, Q., Lipton, J. W., Tong, C. W., Landers, T. M., & Carvey, P. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.017 · Cited by 115
A rat model of Parkinson's disease induced by Japanese encephalitis virus.
Ogata, A., Tashiro, K., Nukuzuma, S., Nagashima, K., & Hall, W. (1997) · Journal of Neurovirology · doi:10.3109/13550289709015803 · Cited by 110
γδ+ T cells are increased in patients with Parkinson's disease
Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Olsson, T. P., & Link, H. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90154-6 · Cited by 108
Postencephalitic parkinsonism – a review
Casals, J., Elizan, T. S., & Yahr, M. D. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050086 · Cited by 108
Rise and fall of minocycline in neuroprotection: need to promote publication of negative results
Diguet, E., Gross, C. E., Tison, F., & Bézard, E. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.016 · Cited by 107
Iron in neurodegenerative disorders
Berg, D., Becker, G., Riederer, P. F., & Rieß, O. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045444 · Cited by 101
Kitamura, Y., Itano, Y., Kubo, T., & Nomura, Y. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90049-3 · Cited by 96
Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP
Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 94
Self-citationGenetic analysis of immunomodulating factors in sporadic Parkinson's disease
Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 94
Mogi, M., Togari, A., Tanaka, K., Ogawa, N., Ichinose, H., & Nagatsu, T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00388-2 · Cited by 85
Dexamethasone pre-treatment interferes with apoptotic death in glioma cells
Gorman, A. M., Hirt, U. A., Orrenius, S., & Ceccatelli, S. (2000) · Neuroscience · doi:10.1016/s0306-4522(99)00565-5 · Cited by 84
Neuronal interferon‐γ immunoreactive molecule: Bioactivities and purification
Olsson, T. P., Bakhiet, M., Höjeberg, B., Ljungdahl, Å., Kelič, S., Edlund, C., Kristensson, K., & van der Meide, P. H. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240205 · Cited by 84
INTERFERON γ GENE EXPRESSION IN RAT CENTRAL NERVOUS SYSTEM GLIAL CELLS
Simone, R. D., Levi, G., & Aloisi, F. (1998) · Cytokine · doi:10.1006/cyto.1997.0314 · Cited by 83
Mattila, K. M., Rinne, J. O., Lehtimäki, T. J., Röyttä, M., Ahonen, J.-P., & Hurme, M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.6.400 · Cited by 82
The iron-responsive element binding protein: a target for synaptic actions of nitric oxide.
Jaffrey, S. R., Cohen, N. A., Rouault, T. A., Klausner, R. D., & Snyder, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12994 · Cited by 81
Mogi, M., Togari, A., Ogawa, M., Ikeguchi, K., Shizuma, N., Dong-shen, F., Nakano, I., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00427-3 · Cited by 77
Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
Hartmann, A., Hunot, S., & Hirsch, É. C. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.004 · Cited by 70
Self-citationHurley, S. D., O’Banion, M. K., Song, D. D., Arana, F. S., Olschowka, J. A., & Haber, S. N. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00273-5 · Cited by 68
Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation
Rowe, D. B., Le, W., Smith, R. G., & Appel, S. H. (1998) · Journal of Neuroscience Research · Cited by 61
Janabi, N., Chabrier, S., & Tardieu, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2129 · Cited by 60
Schneider, J. S., & Denaro, F. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198807000-00006 · Cited by 59
Anatomy and Pathology of the Basal Ganglia
McGeer, P. L., McGeer, E. G., Itagaki, S., & Mizukawa, K. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037756 · Cited by 56
Matsuura, K., Makino, H., & Ogawa, N. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6575 · Cited by 55
Chae, H., Chae, S., Kang, J. S., Bang, B.-G., Cho, S. B., Park, R., So, H. S., Kim, Y. K., Kim, H. M., & Kim, H. (2000) · Endocrinology · doi:10.1210/endo.141.8.7604 · Cited by 53
Carvey, P. M., McRae‐Degueurce, A., Lint, T. F., Ptak, L. R., Lo, E. S., Goetz, C., & Klawans, H. L. (1991) · Neurology · doi:10.1212/wnl.41.5_suppl_2.53 · Cited by 47
A possible role of influenza A virus infection for Parkinson's disease.
Takahashi, M., & Yamada, T. (2001) · PubMed · Cited by 40
Nondopaminergic neurons in Parkinson's disease.
Hirsch, É. C., Orieux, G., Muriel, M.-P., François, C., & Féger, J. (2003) · PubMed · Cited by 40
Kiefer, R., Haas, C. A., & Kreutzberg, G. W. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90270-x · Cited by 37
Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions
McRae‐Degueurce, A., GOTTFRIES, C. ‐., Karlsson, I., Svennerholm, L., & Dahlström, A. B. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07821.x · Cited by 37
Neuronal vascular relationships in the zona compacta of normal and parkinsonian substantia nigra
Issidorides, M. R. (1971) · Brain Research · doi:10.1016/0006-8993(71)90439-2 · Cited by 37
Defazio, G., Toso, R. D., Benvegnuù, D., MINOZZI, M. C., Cananzi, A. R., & Leon, A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91541-5 · Cited by 33
Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease
Fiszer, U., Fredrikson, S., & Członkowska, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00002-0 · Cited by 33
Mizuta, I. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.6.818a · Cited by 32
Catecholamine research : from molecular insights to clinical medicine
Nagatsu, T., Nagashima, T., McCarty, R. C., & Goldstein, D. S. (2002) · Kluwer Academic Publishers-Plenum Publishers eBooks · Cited by 31
Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice
Boireau, A., Bordier, F., Dubédat, P., Pény, C., & Impérato, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00685-x · Cited by 31
Experimental autoimmune nigral damage in guinea pigs
Le, W. D., Engelhardt, J., Xie, W., et al. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00160-p · Cited by 28
Nigral damage and dopaminergic hypofunction in mesencephalon‐immunized guinea pigs
Appel, S. H., Le, W., Tajti, J., Haverkamp, L. J., & Engelhardt, J. I. (1992) · Annals of Neurology · doi:10.1002/ana.410320403 · Cited by 28
Immunoregulation of microglial functional properties
Cross, A. K., & Woodroofe, M. N. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1115 · Cited by 28
ROLE OF CD23 IN ASTROCYTES INFLAMMATORY REACTION DURING HIV-1 RELATED ENCEPHALITIS
Dugas, N., Lacroix, C., Kilchherr, E., Delfraissy, J., & Tardieu, M. (2001) · Cytokine · doi:10.1006/cyto.2001.0896 · Cited by 26
Möller, J. C., Depboylu, C., Kölsch, H., Lohmüller, F., Bandmann, O., Gocke, P., Du, Y., Paus, S., Wüllner, U., Gasser, T., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.058 · Cited by 23
Antibody-dependent cell-mediated cytotoxicity (ADCC) in Parkinson's disease
Bokor, M., Faragó, A., Garam, T., Malatinszky, G., & Schnabel, R. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90065-7 · Cited by 21
Prenatal Lipopolysaccharide Alters Postnatal Dopamine in the Laboratory Rat
Ling, Z., Gayle, D. A., Lipton, J. W., & Carvey, P. M. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4757-3538-3_48 · Cited by 7
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Metadata
- Authors
- Hirsch, E. C., Hunot, S., & Hartmann, A.
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 11
- Pages
- S9-S15
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2162565534
- Cited by
- 296
- References
- 144
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.